Doctors should take warning seriously

doi:10.1136/bmj.311.7020.1638b

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Christine Watson

Senior lecturer in family planning and reproductive health care Division of Obstetrics and Gynaecology, United Medical and Dental Schools of Guy's and St Thomas's Hospitals, London SE1 7EH

EDITOR,--I wish to challenge John Guillebaud's editorial1 on the recent warning by the Committee on Safety of Medicines about combined oral contraceptives containing gestodene and desogestrel.2 Some family planning doctors will not agree with his views on a continued role for preparations that seem to double the risk of venous thromboembolism for current users compared with users of low dose monophasic oral contraceptives containing levonorgestrel and norethisterone. There is …